Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investors

Latest news

  • September 1, 2010

    Theratechnologies is pleased to announce the appointment of a new President and CEO More...

  • August 2, 2010

    Theratechnologies to present at both BMO and Canaccord Genuity Conferences More...

Events

  • From September 20 to 22, 2010

    UBS Global Life Sciences Conference, New York, United States

    Presentation by Yves Rosconi, President & CEO More...

 

Stock information

Symbol TSX : TH
Last trade 4.98
Open 5.00
Net change +0.01
High 5.00
Low 4.96
52 week range 1.83 - 5.75
Volume 52,397
As of 2010-09-02
15:55 EST
Note: Quotes are delayed.
For informational purposes only.